scholarly journals Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I–Modified Peptides

2012 ◽  
Vol 18 (23) ◽  
pp. 6485-6496 ◽  
Author(s):  
Paola Filipazzi ◽  
Lorenzo Pilla ◽  
Luigi Mariani ◽  
Roberto Patuzzo ◽  
Chiara Castelli ◽  
...  
Keyword(s):  
T Cells ◽  
Human Leukocyte Antigen ◽  
Clinical Benefit ◽  
Human Leukocyte Antigen Class ◽  
Human Leukocyte ◽  
Class I ◽  
Leukocyte Antigen ◽  
Modified Peptides ◽  
Melanoma Patients ◽  
Limited Induction

scholarly journals Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity

Immunity ◽  
2008 ◽  
Vol 28 (6) ◽  
pp. 822-832 ◽  
Author(s):  
Diana Chessman ◽  
Lyudmila Kostenko ◽  
Tessa Lethborg ◽  
Anthony W. Purcell ◽  
Nicholas A. Williamson ◽  
...  
Keyword(s):  
T Cells ◽  
Human Leukocyte Antigen ◽  
Cd8 T Cells ◽  
Human Leukocyte Antigen Class ◽  
Drug Hypersensitivity ◽  
Human Leukocyte ◽  
Class I ◽  
Leukocyte Antigen ◽  
Systemic Drug ◽  
Leukocyte Antigen Class I

scholarly journals Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity

Immunity ◽  
2008 ◽  
Vol 29 (1) ◽  
pp. 165 ◽  
Author(s):  
Diana Chessman ◽  
Lyudmila Kostenko ◽  
Tessa Lethborg ◽  
Anthony W. Purcell ◽  
Nicholas A. Williamson ◽  
...  
Keyword(s):  
T Cells ◽  
Human Leukocyte Antigen ◽  
Cd8 T Cells ◽  
Human Leukocyte Antigen Class ◽  
Drug Hypersensitivity ◽  
Human Leukocyte ◽  
Class I ◽  
Leukocyte Antigen ◽  
Systemic Drug ◽  
Leukocyte Antigen Class I
Sign in / Sign up

Export Citation Format

Share Document